Back to Agenda
Welcoming Remarks and Session 1: Keynote: Site and Investigator Perspective on Digital Technology in Clinical Trials
Session Chair(s)
Jonathan Andrus, MS
CEO, CRIO, United States
Welcoming Remarks and Session 1: Keynote: Site and Investigator Perspective on Digital Technology in Clinical Trials
Speaker(s)
Elena A Christofides, MD
Chief Executive Officer, Endocrinology Associates Inc., United States
Shyreen Kamal, PHARMD
Manager, Scientific Programs, DIA, United States
Megan Doyle, JD, MPH
Associate Vice President, Assistant General Counsel - Diagnostics, Eli Lilly and Company, United States
Have an account?
